IBT: NAV up 35.7% as biotech M&A boom drives outperformance

International Biotechnology Trust Plc (LSE:IBT, OTC:IBITF) co-lead fund managers Ailsa Craig and Marek Poszepczynski tell Proactive's Stephen gunnion that...